Web2pro Company Initiatives
With our deep expertise in pharmaceutical distribution, analytics, and information technology, we are committed to using our industry knowhow to help address some of the multitude of issues contributing to the opioid epidemic. We will work with pharmacies, policymakers, prescribers, manufacturers, and others to advance the following initiatives:
National Prescription Safety-Alert System (RxSAS)
To identify patients who are at risk for opioid overuse, abuse, addiction, or misuse, we will invest in the development of a national system that uses prescription information to provide real-time alerts to pharmacists and, ultimately, prescribers, indicating when additional information may be needed before dispensing opioids. To learn more and watch a short video explanation, visit the Prescription Safety Alert System section.
To reduce fraudulent or counterfeit prescriptions, during 2019 we will stop selling opioids to customers¹ who cannot accept e-prescribing of controlled substances and will engage with those customers who may need to make this transition. We continue to advocate that Congress require mandatory e-prescribing of opioids.
To make it easier for doctors to prescribe and pharmacists to dispense in smaller doses, and to reduce potential for unused product, we will proactively engage with all opioid manufacturing partners this calendar year to develop plans for limited-dose packaging.
Fast-track distribution of new, non-opioid pain medications
To improve access to medicines, we will work with manufacturing partners to facilitate immediate availability on a national basis of non-opioid pain medication once approved by FDA.
Free pharmacist training on opioid overdose reversal medications
We will offer pharmacists complimentary training by independent medical experts on how to administer medications such as naloxone.
Educating our customers
We are proactively educating customers about the importance of complying with DEA and state agency regulations and identifying warning signs of prescription abuse and diversion. We provide our customers with literature on how to identify the warning signs of prescription opioid abuse and diversion. We also conduct informational meetings for customer groups and make presentations at medical annual trade shows and pharmacy association meetings to emphasize the importance of preventing diversion.
We are supporting the formation of a foundation dedicated to combatting the crisis and committing $100 million to the newly-formed organization. The foundation is expected to focus on education for patients, caregivers, and providers, addressing key policy issues, and increasing access to life-saving treatments, such as opioid overdose reversal medications. The foundation’s work will be overseen by a board comprised of a majority of outside directors including healthcare and subject matter experts. Details on leadership, strategic priorities, and criteria for giving will be announced in the coming months. This new foundation is distinct from our existing non-profit foundation whose key focus is on supporting better care for cancer patients.
The opioid epidemic is a complicated, multi-faceted public health crisis that cannot be solved by any one participant or idea. It needs to be addressed through a partnership approach that deploys the best thinking across the country. Below are some of the ways that we are working with others to advance unique solutions to help address the opioid crisis.
Helping prevent substance abuse among veterans
As part of our long-standing commitment to supporting veterans, we are working with the Community Anti-Drug Coalitions of America (CADCA) to launch a substance abuse prevention pilot program tailored specifically to veterans. Five community coalitions from CADCA's National Coalition Academy are creating and implementing action plans based on the specific demographics of their local veteran population. We have provided funds to CADCA to create programs, services and tools that are specific to the unique needs of veterans struggling with addiction.
Distributing drug deactivation pouches in Pennsylvania
We joined the Pennsylvania Attorney General's office to help combat opioid abuse by delivering drug deactivation pouches to local communities. Our sales and account management teams worked with pharmacies in the 12 counties to encourage participation. The company leveraged our local distribution centers and transportation network to deliver 300,000 pouches to participating pharmacies.
Building awareness through public education
As part of our membership in the pharmaceutical distributors' trade association, Healthcare Distribution Alliance (HDA), we are supporting the opioid education and awareness campaign.